130 related articles for article (PubMed ID: 15078748)
1. Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients.
Lee DK; Jackson CM; Haggart K; Lipworth BJ
Chest; 2004 Apr; 125(4):1372-7. PubMed ID: 15078748
[TBL] [Abstract][Full Text] [Related]
2. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma.
Lee DK; Bates CE; Currie GP; Lipworth BJ
J Allergy Clin Immunol; 2003 Feb; 111(2):337-41. PubMed ID: 12589354
[TBL] [Abstract][Full Text] [Related]
4. Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids.
Lee DK; Haggart K; Robb FM; Lipworth BJ
Clin Exp Allergy; 2004 Jan; 34(1):110-4. PubMed ID: 14720270
[TBL] [Abstract][Full Text] [Related]
5. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
Fardon TC; Lee DK; Hodge MR; Lipworth BJ
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):259-65. PubMed ID: 16200817
[TBL] [Abstract][Full Text] [Related]
6. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.
Wilson AM; Orr LC; Sims EJ; Dempsey OJ; Lipworth BJ
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1297-301. PubMed ID: 11029334
[TBL] [Abstract][Full Text] [Related]
7. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
[TBL] [Abstract][Full Text] [Related]
10. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.
Wilson AM; Orr LC; Coutie WJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Jan; 32(1):126-32. PubMed ID: 12002729
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
[TBL] [Abstract][Full Text] [Related]
12. A randomized open-label comparative study of montelukast versus theophylline added to inhaled corticosteroid in asthmatic children.
Kondo N; Katsunuma T; Odajima Y; Morikawa A
Allergol Int; 2006 Sep; 55(3):287-93. PubMed ID: 17075269
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
[TBL] [Abstract][Full Text] [Related]
14. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
15. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
[TBL] [Abstract][Full Text] [Related]
16. Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype.
Sims EJ; Jackson CM; Lipworth BJ
Br J Clin Pharmacol; 2003 Jul; 56(1):104-11. PubMed ID: 12848782
[TBL] [Abstract][Full Text] [Related]
17. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.
Stelmach I; Ożarek-Hanc A; Zaczeniuk M; Stelmach W; Smejda K; Majak P; Jerzynska J; Anna J
Pulm Pharmacol Ther; 2015 Apr; 31():42-8. PubMed ID: 25640020
[TBL] [Abstract][Full Text] [Related]
18. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
Dempsey OJ; Wilson AM; Sims EJ; Mistry C; Lipworth BJ
Chest; 2000 Apr; 117(4):950-3. PubMed ID: 10767223
[TBL] [Abstract][Full Text] [Related]
19. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
